Q-Wrapz: Oriel Morrison interviews Roby Zomer, Managing Director of MGC Pharma (ASX:MXC)

Link copied to
clipboard

Stockhead’s Q-Wrapz video series features one-on-one interviews showcasing the latest quarterly results of emerging ASX companies.

In this instalment, former CNBC, Sky News, and Bloomberg news anchor Oriel Morrison interviews Roby Zomer, Co. Founder and Managing Director of MGC Pharmaceuticals Ltd (ASX:MXC).

MGC Pharma is a global biopharma company focused on developing and supplying high-quality phytotherapeutics and phytomedicines to patients in Europe, Australasia, and North America.

The company made headlines in July following news it would commence Phase III clinical trials on efficacy of its CimetrA drug in treating COVID-19 patients.

To learn more about the company’s quarterly highlights, standout areas and forward plan, click on the video above.

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

This field is hidden when viewing the form

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

Spotlight

Phone

This field is for validation purposes and should be left unchanged.

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

V-Cons

V-Con: Medicinal cannabis - which global firms will take the $US35 billion cake?

March 10, 2022 | Stockhead TV

V-Cons

V-Con: Medical cannabis – green grass, green growth

February 4, 2021 | Stockhead TV

StockTalk

StockTalk: Australia’s medicinal cannabis sector is budding again

August 7, 2020 | Stockhead TV